Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mikitaka Iguchi"'
Autor:
Yoshiyuki, Mori, Hideyuki, Tamai, Naoki, Shingaki, Kosaku, Moribata, Hisanobu, Deguchi, Kazuki, Ueda, Izumi, Inoue, Takao, Maekita, Mikitaka, Iguchi, Jun, Kato, Masaki, Terada, Masao, Ichinose
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 45(1)
It has been reported that the apparent diffusion coefficient (ADC) value of hepatocellular carcinomas (HCC) on diffusion-weighted magnetic resonance imaging (MRI) is associated with their histological grade. The present study aimed to evaluate whethe
Autor:
Hideyuki, Tamai, Kosaku, Moribata, Yoshiyuki, Mori, Naoki, Shingaki, Hisanobu, Deguchi, Kazuki, Ueda, Izumi, Inoue, Takao, Maekita, Mikitaka, Iguchi, Jun, Kato, Masao, Ichinose
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 43(7)
Elderly and/or cirrhotic patients with hepatitis C virus (HCV) are at high risk of adverse effects during interferon therapy. The aim of the present study was to evaluate the efficacy, safety and predictive factors for sustained virological response
Autor:
Yuki, Wada, Hideyuki, Tamai, Akiko, Uno, Akira, Kawashima, Naoki, Shingaki, Yoshiyuki, Mori, Kosaku, Moribata, Kaori, Miyata, Katsuhiko, Higashi, Hisanobu, Deguchi, Kazuki, Ueda, Izumi, Inoue, Takao, Maekita, Mikitaka, Iguchi, Jun, Kato, Masao, Ichinose
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 44(2)
Rapid virological response (RVR), defined as serum hepatitis C virus (HCV) RNA negativity at 4 weeks, is the most useful predictor of sustained virological response (SVR) to standard pegylated interferon (PEG IFN) plus ribavirin therapy for patients
Autor:
Hideyuki, Tamai, Naoki, Shingaki, Tatsuya, Shiraki, Hiroshi, Tukuda, Yoshiyuki, Mori, Kosaku, Moribata, Shotaro, Enomoto, Hisanobu, Deguchi, Kazuki, Ueda, Izumi, Inoue, Takao, Maekita, Mikitaka, Iguchi, Kimihiko, Yanaoka, Masashi, Oka, Masao, Ichinose
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 41(12)
Continuation of pegylated interferon (PEG-IFN) plus ribavirin at the recommended dose is difficult in elderly patients and/or patients with cytopenia or complications. Whether the therapeutic efficacy of low-dose PEG-IFN plus ribavirin therapy could
Autor:
Kiyokazu, Shirai, Hideyuki, Tamai, Naoki, Shingaki, Yoshiyuki, Mori, Kosaku, Moribata, Shotaro, Enomoto, Hisanobu, Deguchi, Kazuki, Ueda, Takao, Maekita, Izumi, Inoue, Mikitaka, Iguchi, Kimihiko, Yanaoka, Masashi, Oka, Masao, Ichinose
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 41(8)
To clarify the clinical features of and risk factors for extrahepatic seeding, a major complication following radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). Our prospective database of 351 nodules in 257 patients with HCC who had u
Autor:
Kosaku, Moribata, Hideyuki, Tamai, Naoki, Shingaki, Yoshiyuki, Mori, Shotaro, Enomoto, Tatsuya, Shiraki, Hisanobu, Deguchi, Kazuki, Ueda, Izumi, Inoue, Takao, Maekita, Mikitaka, Iguchi, Kimihiko, Yanaoka, Masashi, Oka, Masao, Ichinose
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 41(3)
Evaluation of malignant potential is important to determine the treatment strategy for small hepatocellular carcinoma (HCC). The aim of the present study was to establish a method of assessing the malignant potential of small hypervascular HCC using
Autor:
Mikitaka Iguchi, Hideyuki Tamai, Tatsuya Shiraki, Masashi Oka, Izumi Inoue, Hisanobu Deguchi, Kimihiko Yanaoka, Naohisa Yahagi, Hirohito Magari, Masao Ichinose, Naoki Shingaki, Kenji Arii, Mitsuhiro Fujishiro, Shotaro Enomoto, Hiroshi Yotsuyanagi, Machiko Takeuchi
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 37(9)
Aims: To compare twice-daily interferon (IFN)-β administration and once-daily IFN-α-2b administration as induction therapy in ribavirin combination therapy in chronic hepatitis C with a high viral load of genotype-1b hepatitis C virus (HCV). Method